Physician profile
Bradley Grant
NPI 1386836518
$9,303.54
in general payments reported to CMS, 2019-2025
20 companies · $6,970 in 2025
The $6,970 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $59.68 · 2021: $75.23 · 2022: $1,467 · 2023: $135 · 2024: $446 · 2025: $6,970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,113 · Food and Beverage: $1,421 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,112.50 |
| Food and Beverage | $1,421.02 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $6,254.84 | 2024-2025 | |
| Alcon Vision LLC | $1,543.76 | 2019-2025 | Precision7, Tryptyr, Rocklatan |
| Bausch & Lomb Americas INC. | $398.24 | 2022-2025 | Infuse, Biotrue, Vyzulta |
| Allergan, INC. | $175.26 | 2019-2022 | |
| Abbvie INC. | $171.71 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $165.73 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $149.08 | 2024-2025 | Vevye |
| Amgen INC. | $87.79 | 2024-2025 | Tepezza |
| Mallinckrodt Hospital Products INC. | $81.32 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $57.67 | 2020-2024 | |
| Oyster Point Pharma, INC. | $45.61 | 2024-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Johnson & Johnson Surgical Vision, INC. | $41.86 | 2023 | Catalys System, Tecnis Simplicity |
| Astellas Pharma US INC | $19.32 | 2023 | Izervay |
| Novartis Pharmaceuticals Corporation | $19.20 | 2023 | |
| Eyevance Pharmaceuticals LLC | $17.74 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $17.69 | 2025 | |
| Maculogix, INC. | $15.53 | 2019 | |
| Coopervision INC. | $15.49 | 2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.08 | 2021 | |
| Abb Con-Cise Optical Group LLC | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.